Skip to content

Protégé™ GPS™ SERB65-09-40-80Recalls & reported problems

Ev3, Inc · STENT SERB65-09-40-80 PROTEGE GPS V05 · Class 3 · Implant

All models of Protégé GPS (26)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00821684071441), received between Dec 21, 2016 and Dec 21, 2016 — classified as 1 injury.

The most frequently reported specific device problem is “Inaccurate Delivery” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Inaccurate Delivery1

Patient problems

  • Patient Problem/Medical Problem1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 21, 2016Inaccurate Delivery; Inaccurate Delivery

    THE PHYSICIAN USED THE PROTÉGÉ GPS 9X40 TO TREAT A LESION IN THE GREAT SAPHENOUS VEIN WITH 90% STENOSIS AS PER IFU. IT WAS REPORTED THE STENT WAS ADVANCED WITH NO RESISTANCE NOTED; THE STENT JUMPED AND MISSED THE TARGET LESION. THE PHYSICIAN USED A 9X60X120 TO EXTEND THE STENT, TO COVER THE LESION. THE PROCEDURE WAS SUCCESSFUL WITH NO ISSUES NOTED. NO ISSUES WITH EITHER SIDE OF THE STENTS. THE EXTENSION WAS ACCEPTABLE WITH NO NEGATIVE OUTCOMES TO THE PATIENT. NO FURTHER CLINICAL SEQUELAE REPORTED.

    Patient problems: Patient Problem/Medical Problem

    MAUDE report 6192934 ↗

Other STENT, ILIAC devices

All STENT, ILIAC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page